Today, FDA announced a public meeting to give interested persons an opportunity to discuss the use of the term “healthy” in the labeling of human food.
- As previously covered on
Legal and Regulatory updates for the food and supplement industry
Today, FDA announced a public meeting to give interested persons an opportunity to discuss the use of the term “healthy” in the labeling of human food.
As previously reported on this blog, FDA issued a revised Draft Guidance titled, “Dietary Supplements: New Dietary Ingredient [NDI] Notifications and Related Issues,” in August 2016. The Agency received…
Continue Reading Supplement Spotlight: FDA Revised NDI Draft Guidance Does Not Alleviate Industry’s Concerns
The Grocery Manufacturers of America (GMA) has requested that the short-term sodium reduction goals be extended to at least four years, and that FDA account for differing functional roles of …
Continue Reading Scaling Back Sodium: GMA Comments on Short-term Sodium Reduction Guidelines
…
Continue Reading FDA Updates Food Facility Registration Product Categories
On the heels of recently released draft guidance concerning substantiation for infant formula structure/function claims, FDA has issued guidance regarding the labeling of infant formula.
…
Continue Reading FDA Issues Guidance for the Labeling of Infant Formula
FDA has extended the comments period for its draft guidance regarding sodium reduction in food.
…
Continue Reading Scaling Back Sodium – FDA Extends Comments Period for Draft Guidance
…
Continue Reading Supplement Spotlight: FDA Revises NDI Draft Guidance
FDA finalizes guidance on declaration of small amounts of nutrients and dietary ingredients on nutrition labels.